FANFARE ENTERTAINMENT AND MUSES LABS
PARTNER TO CREATE GROUNDBREAKING APP TO ENABLE MENDTM PROTOCOL FOR ALZHEIMER’S DISEASE
Acclaimed mobile platform company FANFARE ENTERTAINMENT has partnered with MUSES LABS to help optimize treatment and prevention of Alzheimer’s diseaseby enabling individuals with Alzheimer’s disease to benefit from the MENDtm Protocol. Set for release this fall, a new App developed by FANFARE ENTERTAINMENT will help individuals with Alzheimer’s disease, their caregivers, family members, and doctors with a set of monitoring, measuring, testing, tracking, motivation, and adherence functions.
According to the Alzheimer’s Association, Alzheimer’s disease is the sixth leading cause of death in the United States, and is the only cause of death among the top 10 causes that cannot be prevented, cured or slowed. There are an estimated 5.4 million Alzheimer’s patients in the US alone. There are roughly 75 million people in the US with the ApoE4 gene, which places them at a significantly-higher risk of developing Alzheimer’s disease and would benefit from taking steps to prevent it.
The MEND (metabolic enhancement for neurodegeneration) Protocol defines a personalized combination therapy for Alzheimer’s disease, and was the first to show reversal of cognitive decline in patients with early Alzheimer’s disease or its precursors, mild cognitive impairment (MCI) or subjective cognitive impairment (SCI). The MEND Protocol is based on a broad understanding of the pathogenesis of Alzheimer’s disease and targets the multiple interrelated underlying biological mechanisms of Alzheimer’s disease simultaneously. The Protocol consists of a complex combination therapy that is personalized for each individual. The personalization encompasses an individual’s genome, blood chemistry, medical history, medications, and other factors. The personalization process is enabled by technology developed by Muses Labs.
Developed in close collaboration between MUSES LAB and FANFARE ENTERTAINMENT, the new App is focused on motivating and coaching individuals through the MEND Protocol. The App is designed to be highly engaging, as it incorporates the best research on motivation, collaboration, and gaming. In addition to motivation and coaching, the App securely gathers data on adherence and cognitive function to inform authorized physicians and caregivers in maintaining an environment designed to improve outcomes. Dr. Dale Bredesen, who created the MEND protocol, says: “Motivation and reminders from thoughtfully-designed technology solutions, helping patients adhere to their therapy and track their progress, are essential to meeting the goals of this multi-faceted protocol.”
Muses Labs CEO Vik Chandra says, “For a protocol to be effective, individuals have to be able to adhere to it. Driving adherence among individuals with MCI and Alzheimer’s disease is a problem that calls for novel solutions. Fanfare’s unique platform, skills, and ability to leverage the latest eHealth developments from vendors such as Apple are key to enabling patients to adhere to their protocols and to collaborate with their physicians and caregivers. The capabilities of Muses Labs and Fanfare together will lead a transformation in the care of individuals with complex diseases.”
Fanfare Entertainment has partnered with artists like Keith Urban, Heart, and Bryan Adams, as well as brands including Nobu and Jim Shore, to create dynamic, interactive apps. The company members are now excited to be deploying the technology platform they have created and applying it to something as urgent as Alzheimer’s care. Lance Kelly, CEO of Fanfare says, “All of us are aware of someone whose life has been dramatically impacted by Alzheimer’s disease. We are privileged to partner with Muses Labs and to have the opportunity to utilize our sophisticated platform and talents to support the MEND Protocol.”
About Fanfare Entertainment, LLC:
Fanfare Entertainment is a privately-funded company based in Burlingame, California. The company focuses on delivering mobile experiences that engage consumers in music, sports, entertainment, consumer products, and other brand-intensive industries. Fanfare brings new revenue streams to brands and artists through its unique mobile apps, and through Rifftime, an innovative record label and musician showcase targeting veteran and amateur artists alike. To learn more, visit http://www.fanfareentertainment.com.
About Muses Labs:
Muses Labs (http://museslabs.com), delivers software-based services to enable personalized protocols for the treatment of Alzheimer’s disease. Muses Labs enables physicians to apply the MENDTM Protocol for addressing individuals with Alzheimer’s disease and its precursors. The MEND (Metabolic Enhancement for NeuroDegeneration) Protocol enables a combination therapy for Alzheimer’s disease that is based on a broad understanding of the pathogenesis of Alzheimer’s disease, and aims to target multiple interrelated underlying biological mechanisms simultaneously.